FDA Issues Early Communication About Ongoing Safety Review of Weight Loss Drug Orlistat
No abstract is available. To read the body of this article, please view the Full Text online.
PII: S0016-5085(09)01655-2
doi:10.1053/j.gastro.2009.09.014
© 2009 Published by Elsevier Inc.


